Findings from Tianyi Wang and Co-Researchers Advance Knowledge in Personalized Medicine (Payer coverage principles for precision medicine biomarker testing in oncology): Drugs and Therapies – Personalized Medicine

2026 AUG 26 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- New research on Drugs and Therapies - Personalized Medicine is the subject of a report. According to news originating from New York City, New York, by NewsRx correspondents, research stated, “In 2025, the Academy of Managed Care Pharmacy (AMCP) held a 2-day partnership forum on the topic of advancing precision medicine access in oncology. Precision medicine, in this context, focuses on biomarker testing required to create personalized treatment plans and procedures.”

Our news journalists obtained a quote from the research, “The forum brought together patients; payers, including health insurers and employer groups; pharmacy benefit managers; providers; pathologists; laboratory benefit managers; and leaders from patient advocacy organizations, coalitions, and professional associations. In response to fundamental coverage challenges impacting patient access to biomarker testing, the overarching goal of the forum was to collaboratively ideate deliverables to drive a standardized approach to assessing and determining coverage. A critical deliverable from this initiative included 8 guiding principles for managed care stakeholders as it relates to the coverage of biomarker testing.”

According to the news editors, the research concluded: “This article provides detail on each guiding principle, which are considerations intended to guide managed care decision-makers on determining and monitoring coverage for biomarker-driven testing used to inform treatment decisions in oncologic indications.”

This research has been peer-reviewed.

For more information on this research see: Payer coverage principles for precision medicine biomarker testing in oncology. Journal of Managed Care & Specialty Pharmacy, 2026;32. Journal of Managed Care & Specialty Pharmacy can be contacted at: Acad Managed Care Pharmacy, 100 N Pitt St, 400, Alexandria, VA 22314-3134, USA.

The news correspondents report that additional information may be obtained from Tianyi Wang, Omnicom Health Market Access, New York, NY. Additional authors for this research include Steven S. Kheloussi, Kimberly Tsai, Dana McCormick and Pamala A. Pawloski.

The publisher’s contact information for the Journal of Managed Care & Specialty Pharmacy is: Acad Managed Care Pharmacy, 100 N Pitt St, 400, Alexandria, VA 22314-3134, USA.

(Our reports deliver fact-based news of research and discoveries from around the world.)